These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 30125689)

  • 1. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
    Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
    BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis.
    Dhana A; Hamada Y; Kengne AP; Kerkhoff AD; Broger T; Denkinger CM; Rangaka MX; Gupta-Wright A; Fielding K; Wood R; Huerga H; Rücker SCM; Bjerrum S; Johansen IS; Thit SS; Kyi MM; Hanson J; Barr DA; Meintjes G; Maartens G
    J Infect; 2022 Jul; 85(1):40-48. PubMed ID: 35588942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
    Peter JG; Theron G; Muchinga TE; Govender U; Dheda K
    PLoS One; 2012; 7(7):e39966. PubMed ID: 22815718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
    Floridia M; Ciccacci F; Andreotti M; Hassane A; Sidumo Z; Magid NA; Sotomane H; David M; Mutemba E; Cebola J; Mugunhe RJ; Riccardi F; Marazzi MC; Giuliano M; Palombi L; Mancinelli S
    Clin Infect Dis; 2017 Nov; 65(11):1878-1883. PubMed ID: 29020319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag.
    Esmail A; Pooran A; Sabur NF; Fadul M; Brar MS; Oelofse S; Tomasicchio M; Dheda K
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32727831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia.
    Siddiqi OK; Birbeck GL; Ghebremichael M; Mubanga E; Love S; Buback C; Kosloff B; Ayles H; Atadzhanov M; Dheda K; Koralnik IJ
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
    Shah M; Ssengooba W; Armstrong D; Nakiyingi L; Holshouser M; Ellner JJ; Joloba M; Manabe YC; Dorman SE
    AIDS; 2014 Jun; 28(9):1307-14. PubMed ID: 24637544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
    Huerga H; Ferlazzo G; Bevilacqua P; Kirubi B; Ardizzoni E; Wanjala S; Sitienei J; Bonnet M
    PLoS One; 2017; 12(1):e0170976. PubMed ID: 28125693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study.
    Kebede W; Abebe G; Gudina EK; Van Rie A
    Sci Rep; 2021 Dec; 11(1):24428. PubMed ID: 34952913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
    Nakiyingi L; Nonyane BA; Ssengooba W; Kirenga BJ; Nakanjako D; Lubega G; Byakika-Kibwika P; Joloba ML; Ellner JJ; Dorman SE; Mayanja-Kizza H; Manabe YC
    PLoS One; 2015; 10(7):e0133756. PubMed ID: 26222142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
    Yoon C; Semitala FC; Asege L; Katende J; Mwebe S; Andama AO; Atuhumuza E; Nakaye M; Armstrong DT; Dowdy DW; McCulloch CE; Kamya M; Cattamanchi A
    Am J Respir Crit Care Med; 2019 Mar; 199(5):643-650. PubMed ID: 30192649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary Nonsputum Diagnostic Testing for Tuberculosis in People with HIV Using Oral Swab PCR and Urine Lipoarabinomannan Detection.
    Shapiro AE; Olson AM; Kidoguchi L; Niu X; Ngcobo Z; Magcaba ZP; Ngwane MW; Whitman GR; Weigel KM; Wood RC; Wilson DPK; Drain PK; Cangelosi GA
    J Clin Microbiol; 2022 Aug; 60(8):e0043122. PubMed ID: 35913145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial).
    Mangu C; Cossa M; Ndege R; Khosa C; Leukes V; de la Torre-Pérez L; Machiana A; Kivuma B; Mnzava D; Zachariah C; Manjate P; Tagliani E; Schacht C; Buech J; Singh S; Ehrlich J; Riess F; Sanz S; Kranzer K; Cox H; Sabi I; Nguenha D; Meggi B; Weisser M; Ntinginya N; Schumacher S; Ruhwald M; Penn-Nicholson A; Garcia-Basteiro AL;
    BMC Infect Dis; 2024 Aug; 24(1):831. PubMed ID: 39148008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.